Filing Details

Accession Number:
0001209191-10-047488
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-24 21:20:36
Reporting Period:
2010-09-24
Filing Date:
2010-09-24
Accepted Time:
2010-09-24 21:20:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376260 P. Christopher Lowe C/O Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard, Suite B
Hayward CA 94545
Cfo & Vp Of Administration No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-24 5,000 $4.18 62,523 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,637 Indirect By spouse
Common Stock 80,997 Indirect By BioVest III
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.04 to $4.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. Mr. Lowe is a principal of BioVest III, which directly holds the reported securities, and as such, may be deemed to have sole voting and investment power with respect to such securities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.